| Name | Title | Contact Details |
|---|
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Oasis For Orphans (o4o.org) is a non-profit organization dedicated to giving children in Kenya hope for a bright future. We believe that education is the key to unlocking opportunities, but when physical and educational needs are not met, the future be...
The Roberts Group, Inc. is a Waukesha, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InSound Medical, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Solvay Pharmaceuticals Inc is a Marietta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.